Ghost Tree Capital’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-225,000	Closed	-$3.66M	–	55
2024 Q2	$3.66M	Hold	225,000	–	–	1.14%	34
2024 Q1	$4.16M	Buy	225,000 +175,000	+350%	+$4.34M	1.15%	28
2023 Q4	$1.57M	Sell	50,000 -30,000	-38%	-$716K	0.51%	44
2023 Q3	$1.67M	Buy	+80,000	New	+$2.17M	0.55%	51
2020 Q3	–	Sell	-165,000	Closed	-$8M	–	47
2020 Q2	$8M	Buy	+165,000	New	+$7.92M	2.11%	21
2019 Q3	–	Sell	-750,000	Closed	-$20M	–	45
2019 Q2	$20M	Sell	750,000 -150,000	-17%	-$3.83M	4.16%	8
2019 Q1	$24.2M	Buy	900,000 +775,000	+620%	+$18.1M	6.31%	2
2018 Q4	$2.02M	Sell	125,000 -375,000	-75%	-$7.28M	0.73%	32
2018 Q3	$10.4M	Sell	500,000 -35,000	-7%	-$551K	2.21%	16
2018 Q2	$8.17M	Buy	535,000 +135,000	+34%	+$2.41M	2.4%	14
2018 Q1	$8.99M	Buy	+400,000	New	+$11.1M	1.82%	18
2017 Q3	–	Sell	-275,000	Closed	-$8.95M	–	64
2017 Q2	$7.67M	Sell	275,000 -75,000	-21%	-$2.24M	1.59%	23
2017 Q1	$12M	Buy	350,000 +250,000	+250%	+$8.82M	2.24%	11
2016 Q4	$2.88M	Sell	100,000 -100,000	-50%	-$2.65M	0.69%	48
2016 Q3	$6.36M	Buy	+200,000	New	+$6.78M	1.03%	36
2016 Q2	–	Sell	-75,000	Closed	-$2.1M	–	65
2016 Q1	$2.1M	Sell	75,000 -175,000	-70%	-$3.82M	1.19%	27
2015 Q4	$8.91M	Buy	+250,000	New	+$8.81M	3.65%	9
2015 Q2	–	Sell	-120,000	Closed	-$3.91M	–	72
2015 Q1	$3.91M	Buy	+120,000	New	+$4.12M	1.41%	31